Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement. [electronic resource]
Producer: 20051003Description: 977-86 p. digitalISSN:- 0884-0431
- Adolescent
- Anti-Inflammatory Agents -- therapeutic use
- Body Height
- Bone Density
- Bone Development -- drug effects
- Bone and Bones -- drug effects
- Child
- Child, Preschool
- Densitometry
- Diphosphonates -- therapeutic use
- Fractures, Bone -- prevention & control
- Growth Hormone -- therapeutic use
- Humans
- Osteogenesis Imperfecta -- drug therapy
- Pamidronate
- Spine -- drug effects
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.